Literature DB >> 23478972

Activity of halogeno-thiazolides against Cryptosporidium parvum in experimentally infected immunosuppressed gerbils (Meriones unguiculatus).

Gilles Gargala1, Arnaud François, Loïc Favennec, Jean-François Rossignol.   

Abstract

Nitazoxanide and three halogeno-thiazolides, RM-4850, RM-4865, and RM-5038, were tested against Cryptosporidium parvum in experimentally infected immunosuppressed Mongolian gerbils. Daily 400-mg/kg doses of the four test drugs for 5 to 8 consecutive days produced similar reductions of oocyst shedding. Using early-infected gerbils, a shorter 4-day treatment with RM-5038 reduced oocyst shedding by 95%, compared to 47% for nitazoxanide (P = 0.02), suggesting that RM-5038 is more effective than nitazoxanide under the experimental conditions used.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23478972      PMCID: PMC3716183          DOI: 10.1128/AAC.01538-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Inhibitory activities of epidermal growth factor receptor tyrosine kinase-targeted dihydroxyisoflavone and trihydroxydeoxybenzoin derivatives on Sarcocystis neurona, Neospora caninum, and Cryptosporidium parvum development.

Authors:  G Gargala; A Baishanbo; L Favennec; A François; J J Ballet; J-F Rossignol
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

2.  Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase-Bim axis and reveals glutathione-S-transferase P1 as Achilles' heel.

Authors:  D Sidler; A Brockmann; J Mueller; U Nachbur; N Corazza; P Renzulli; A Hemphill; T Brunner
Journal:  Oncogene       Date:  2011-12-12       Impact factor: 9.867

3.  Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni.

Authors:  Paul S Hoffman; Gary Sisson; Matthew A Croxen; Kevin Welch; W Dean Harman; Nunilo Cremades; Michael G Morash
Journal:  Antimicrob Agents Chemother       Date:  2006-12-11       Impact factor: 5.191

4.  Identification of isoflavone derivatives as effective anticryptosporidial agents in vitro and in vivo.

Authors:  Andrew V Stachulski; Neil G Berry; A C Lilian Low; Shelley L Moores; Eleanor Row; David C Warhurst; Ipemida S Adagu; Jean-François Rossignol
Journal:  J Med Chem       Date:  2006-02-23       Impact factor: 7.446

5.  Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells.

Authors:  Joachim Müller; Daniel Sidler; Ueli Nachbur; Jonathan Wastling; Thomas Brunner; Andrew Hemphill
Journal:  Int J Cancer       Date:  2008-10-15       Impact factor: 7.396

6.  Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species.

Authors:  Glenn A Pankuch; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

7.  In vitro efficacy of nitro- and halogeno-thiazolide/thiadiazolide derivatives against Sarcocystis neurona.

Authors:  G Gargala; L Le Goff; J J Ballet; L Favennec; A V Stachulski; J F Rossignol
Journal:  Vet Parasitol       Date:  2009-03-25       Impact factor: 2.738

8.  Evaluation of new thiazolide/thiadiazolide derivatives reveals nitro group-independent efficacy against in vitro development of Cryptosporidium parvum.

Authors:  Gilles Gargala; Laetitia Le Goff; Jean-Jacques Ballet; Loic Favennec; Andrew V Stachulski; Jean-François Rossignol
Journal:  Antimicrob Agents Chemother       Date:  2010-01-04       Impact factor: 5.191

  8 in total
  5 in total

1.  Assessment of chitosan nanoparticles in improving the efficacy of nitazoxanide on cryptosporidiosis in immunosuppressed and immunocompetent murine models.

Authors:  Howayda Said Fouad Moawad; Mohamed Hegab Abd El-Hady Hegab; Maha Saber Reda Badawey; Shaimaa Elsayed Ashoush; Shereen Mahmoud Ibrahim; Amira Abd El-Lateef Saleh Ali
Journal:  J Parasit Dis       Date:  2021-01-06

2.  Revisiting the global problem of cryptosporidiosis and recommendations.

Authors:  Arpit Kumar Shrivastava; Subrat Kumar; Woutrina A Smith; Priyadarshi Soumyaranjan Sahu
Journal:  Trop Parasitol       Date:  2017 Jan-Jun

Review 3.  Comparative Pathobiology of the Intestinal Protozoan Parasites Giardia lamblia, Entamoeba histolytica, and Cryptosporidium parvum.

Authors:  Andrew Hemphill; Norbert Müller; Joachim Müller
Journal:  Pathogens       Date:  2019-07-29

Review 4.  An update on Cryptosporidium biology and therapeutic avenues.

Authors:  Ajit Kumar Dhal; Chinmaya Panda; Soon-Il Yun; Rajani Kanta Mahapatra
Journal:  J Parasit Dis       Date:  2022-06-22

Review 5.  Nitazoxanide: a first-in-class broad-spectrum antiviral agent.

Authors:  Jean-François Rossignol
Journal:  Antiviral Res       Date:  2014-08-07       Impact factor: 5.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.